Leveraging extensive expertise in private equity, the fund manager has built a diverse portfolio primarily targeting technology and healthcare sectors across North America and Europe. With a strategic focus on operator-first investments, they have executed over 25 deals, demonstrating a keen ability to identify high-growth opportunities. Notable exits include a successful sale in the biotech space that yielded substantial returns. Their data-driven approach enhances due diligence, ensuring robust decision-making throughout the investment lifecycle.